Johan P. Kuijvenhoven
Hoofddorp, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Urinary and Faecal Amino-Acids as Biomarkers for Colorectal Neoplasia in Lynch Syndrome-A Prospective Longitudinal Study.
Journal: International journal of cancer
Published: January 21, 2026
Thrombophlebitis of the Umbilical Vein: A Rare Complication of Acute Pancreatitis.
Journal: Journal of gastrointestinal and liver diseases : JGLD
Published: November 08, 2024
Faecal Volatile Organic Compounds to Detect Colorectal Neoplasia in Lynch Syndrome-A Prospective Longitudinal Multicentre Study.
Journal: Alimentary pharmacology & therapeutics
Published: July 22, 2024
Fecal Immunochemical Test to Detect Colorectal Neoplasia in Lynch Syndrome: A Prospective Multicenter Study.
Journal: The American journal of gastroenterology
Published: May 06, 2024
Multicentre study and systematic review: Allopurinol exposure during pregnancy.
Journal: Alimentary pharmacology & therapeutics
Published: January 11, 2024
Discontinuation of infliximab treatment in patients with inflammatory bowel disease who retransitioned to originator and those who remained on biosimilar.
Journal: Therapeutic advances in gastroenterology
Published: March 27, 2023
Exposure to Thioguanine During 117 Pregnancies in Women With Inflammatory Bowel Disease.
Journal: Journal of Crohn's & colitis
Published: December 15, 2022
Integration of stool microbiota, proteome and amino acid profiles to discriminate patients with adenomas and colorectal cancer.
Journal: Gut microbes
Published: November 12, 2022
The potential of fecal microbiota and amino acids to detect and monitor patients with adenoma.
Journal: Gut microbes
Published: February 21, 2022
Lower Risk of Recurrence with a Higher Induction Dose of Mesalazine and Longer Duration of Treatment in Ulcerative Colitis: Results from the Dutch, Non-Interventional, IMPACT Study.
Journal: Journal of gastrointestinal and liver diseases : JGLD
Published: July 26, 2021
Switching TNFα inhibitors: Patterns and determinants.
Journal: Pharmacology research & perspectives
Published: June 27, 2021
Switching From Reference Infliximab to Biosimilar CT-P13 Did Not Change Quality of Life in Stable Inflammatory Bowel Disease Patients.
Journal: Crohn's & colitis 360
Published: June 03, 2020
Last Updated: 09/26/2026